Jury Awards $2.75 Million in HRT Breast Cancer Case

LITTLE ROCK, Ark. - A federal jury has awarded $2.75 million to a woman who claimed she developed breast cancer after years of ingesting hormone replacement therapy drugs manufactured by Wyeth and Pharmacia & Upjohn. Scroggin v. Wyeth, et al., No. 04-1169 (E.D. Ark.).

Jurors in the U.S. District Court for the Eastern District of Arkansas returned the verdict Feb. 25 after deliberating for two days. They found that Donna Scroggin proved by the greater weight of the evidence the manufacturers' inadequate warnings for their HRT drug combination proximately caused Scroggin's cancer.

The jury also determined that the defendants failed …